This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hom, R C Articles by Ruprecht, R M Search for Related Content PubMed PubMed Citation Articles by Hom, R C Articles by Ruprecht, R M

 Previous Article  |  Next Article 

J Virol. 1991 January; 65(1): 220-224

Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells.

Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Boston, Massachusetts.

ABSTRACT

We have found previously that postexposure chemoprophylaxis with 3'-azido-3'-deoxythymidine (also known as zidovudine or AZT) in combination with recombinant human alpha A/D interferon fully protected mice exposed to a lethal dose of Rauscher murine leukemia virus (RLV) against viremia and disease. After cessation of therapy, over 90% of these mice were able to resist rechallenge with live RLV, thus demonstrating an acquired immunity. Adoptive cell transfer of 4 x 10(7) cells from immunized mice fully protected naive recipients from viremia and splenomegaly after RLV challenge. However, when these immune T cells were fractionated into CD4+ and CD8+ subpopulations, only partial protection was found when 4 x 10(7) T cells of either subset were given. Full protection against RLV challenge was seen again when the T-cell subsets from immunized mice were recombined and transferred at the same number into naive mice. We conclude that cellular immunity alone is protective and that both CD4+ and CD8+ cell types are required for conferring full protection against live virus challenge.

This article has been cited by other articles:

• Schmitz, J. E., Johnson, R. P., McClure, H. M., Manson, K. H., Wyand, M. S., Kuroda, M. J., Lifton, M. A., Khunkhun, R. S., McEvers, K. J., Gillis, J., Piatak, M., Lifson, J. D., Grosschupff, G., Racz, P., Tenner-Racz, K., Rieber, E. P., Kuus-Reichel, K., Gelman, R. S., Letvin, N. L., Montefiori, D. C., Ruprecht, R. M., Desrosiers, R. C., Reimann, K. A. (2005). Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239{Delta}3-Vaccinated Rhesus Macaques. J. Virol. 79: 8131-8141 [Abstract] [Full Text]  
• Norris, P. J., Sumaroka, M., Brander, C., Moffett, H. F., Boswell, S. L., Nguyen, T., Sykulev, Y., Walker, B. D., Rosenberg, E. S. (2001). Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones. J. Virol. 75: 9771-9779 [Abstract] [Full Text]  
• Lifson, J. D., Rossio, J. L., Arnaout, R., Li, L., Parks, T. L., Schneider, D. K., Kiser, R. F., Coalter, V. J., Walsh, G., Imming, R. J., Fisher, B., Flynn, B. M., Bischofberger, N., Piatak, M. Jr., Hirsch, V. M., Nowak, M. A., Wodarz, D. (2000). Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment. J. Virol. 74: 2584-2593 [Abstract] [Full Text]  
• Perrin, G., Schnuriger, V., Quiquerez, A.-L., Saas, P., Pannetier, C., de Tribolet, N., Tiercy, J.-M., Aubry, J.-P., Dietrich, P.-Y., Walker, P. R. (1999). Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. Int Immunol 11: 1337-1350 [Abstract] [Full Text]  
• Stohlman, S. A., Bergmann, C. C., Lin, M. T., Cua, D. J., Hinton, D. R. (1998). CTL Effector Function Within the Central Nervous System Requires CD4+ T Cells. J. Immunol. 160: 2896-2904 [Abstract] [Full Text]  
• Salk, J, Bretscher, P., Salk, P., Clerici, M, Shearer, G. (1993). A strategy for prophylactic vaccination against HIV. Science 260: 1270-1272